These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6980497

  • 21. Fibrinopeptide A release by factor-IX concentrates and FEIBA fraction (factor eight inhibitor bypassing activity).
    Hofmann V, Straub PW.
    Thromb Res; ; 20(5-6):623-31. PubMed ID: 6785894
    [No Abstract] [Full Text] [Related]

  • 22. Studies on the effect of heat treatment on the thrombogenicity of factor IX concentrates in dogs.
    Littlewood JD, Dawes J, Smith JK, Feldman PA, Haddon ME, McQuillan TA, Foster PR, Ferguson J, Prowse CV.
    Br J Haematol; 1987 Apr; 65(4):463-8. PubMed ID: 3580303
    [Abstract] [Full Text] [Related]

  • 23. Analysis of the procoagulant activities of factor IX concentrates.
    Mackie IJ, Seghatchian MJ.
    Thromb Res; 1982 Nov 15; 28(4):499-507. PubMed ID: 6819651
    [Abstract] [Full Text] [Related]

  • 24. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B, Griffin JH.
    Clin Haematol; 1985 Jun 15; 14(2):281-342. PubMed ID: 2994929
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Factor Xa and prothrombin: mechanism of action of FEIBA.
    Turecek PL, Varadi K, Gritsch H, Auer W, Pichler L, Eder G, Schwarz HP.
    Vox Sang; 1999 Jun 15; 77 Suppl 1():72-9. PubMed ID: 10529694
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity.
    Negrier C, Goudemand J, Sultan Y, Bertrand M, Rothschild C, Lauroua P.
    Thromb Haemost; 1997 Jun 15; 77(6):1113-9. PubMed ID: 9241742
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.